Litcius/Paper detail

Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination

Christine Happle, Markus Hoffmann, Amy Kempf, Inga Nehlmeier, Metodi V. Stankov, Noemí Calderón Hampel, Torsten Witte, Stefan Pöhlmann, Georg M. N. Behrens, Alexandra Dopfer‐Jablonka

2024The Lancet Infectious Diseases25 citationsDOIOpen Access PDF

Topics & Concepts

VaccinationVirologyImmunityHumoral immunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Biology2019-20 coronavirus outbreakMessenger RNAImmunologyMedicineAntibodyImmune systemOutbreakGeneticsGeneInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesHeparin-Induced Thrombocytopenia and Thrombosis
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination | Litcius